A study of 241 people with multiple sclerosis in Germany shows acceptance of AI depends on the specific task. Participants favor AI for low-risk functions like ongoing monitoring over complex clinical decisions. This suggests PLOS researchers must prioritize transparency and low-stakes utility to drive patient adoption in chronic disease management.